tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Biodexa Pharmaceuticals activates first European Site for Phase 3 Serenta trial
PremiumThe FlyBiodexa Pharmaceuticals activates first European Site for Phase 3 Serenta trial
29d ago
Biodexa Pharmaceuticals files to sell 3.38M units
Premium
The Fly
Biodexa Pharmaceuticals files to sell 3.38M units
1M ago
Biodexa Pharmaceuticals’ Phase 3 Serenta Trial Approved in Europe
Premium
Company Announcements
Biodexa Pharmaceuticals’ Phase 3 Serenta Trial Approved in Europe
2M ago
Biodexa says requirement for financing represents ‘material uncertainty’
PremiumThe FlyBiodexa says requirement for financing represents ‘material uncertainty’
3M ago
Biodexa Pharmaceuticals reports 1H EPS (GBP0.0002) vs. (GBP0.001) last year
Premium
The Fly
Biodexa Pharmaceuticals reports 1H EPS (GBP0.0002) vs. (GBP0.001) last year
3M ago
Biodexa Pharmaceuticals Begins Phase 3 Trial for FAP Treatment
Premium
Company Announcements
Biodexa Pharmaceuticals Begins Phase 3 Trial for FAP Treatment
4M ago
Biodexa Pharmaceuticals Announces ADR Ratio Change Effective July 31, 2025
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Announces ADR Ratio Change Effective July 31, 2025
5M ago
Biodexa Pharmaceuticals files CTA in Europe for Phase 3 Serenta trial
Premium
The Fly
Biodexa Pharmaceuticals files CTA in Europe for Phase 3 Serenta trial
5M ago
Biodexa Pharmaceuticals Announces Successful AGM Resolutions
Premium
Company Announcements
Biodexa Pharmaceuticals Announces Successful AGM Resolutions
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100